Scrip Asia 100 companies showed a return to greater operating profitability for financial year 2015 despite reduced overall dollar-denominated pharmaceutical sales.
The full Scrip Asia 100 data set for 2017 is now available and includes data on R&D Spending, Total Revenues, Assets, Operating Profit and Sales.
If you are a Scrip subscriber, click here to download the data in Excel format.
Chapter sponsored by:
You must sign in to use this functionality.
Please Sign In
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with active subscriptions will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.